ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

KTRA Kintara Therapeutics Inc

0.2952
-0.0218 (-6.88%)
May 31 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Kintara Therapeutics Inc KTRA NASDAQ Common Stock
  Price Change Price Change % Share Price Last Trade
-0.0218 -6.88% 0.2952 18:59:56
Open Price Low Price High Price Close Price Previous Close
0.2726 0.2365 0.339 0.3104 0.317
more quote information »

Recent News

Date Time Source Heading
5/17/202415:10EDGAR2Form ARS - Annual Report to Security Holders
5/17/202415:05EDGAR2Form DEF 14A - Other definitive proxy statements
5/14/202415:55EDGAR2Form 425 - Prospectuses and communications, business..
5/14/202415:50EDGAR2Form 8-K - Current report
5/14/202415:45PRNUSKintara Therapeutics Announces Fiscal 2024 Third Quarter..
5/14/202415:40EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
5/13/202415:06EDGAR2Form S-4 - Registration of securities, business combinations
4/05/202412:09PRNUSKuehn Law Encourages KTRA, ABIO, SWAV, and NS Investors to..
4/03/202406:00PRNUSKintara Therapeutics and TuHURA Biosciences Enter into..
3/27/202408:00PRNUSKintara Therapeutics Announces Expansion of REM-001 Clinical..
2/27/202405:59EDGAR2Form 8-K - Current report
2/26/202406:00EDGAR2Form 8-K - Current report
2/22/202406:00EDGAR2Form 8-K - Current report
2/14/202415:07PRNUSKintara Therapeutics Announces Fiscal 2024 Second Quarter..
2/12/202408:05EDGAR2Form 8-K - Current report
2/12/202408:00PRNUSKintara Therapeutics Announces Initiation of REM-001..
12/18/202315:10EDGAR2Form 8-K - Current report
12/18/202315:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
12/15/202315:15EDGAR2Form 8-K - Current report
12/07/202308:10EDGAR2Form 8-K - Current report
12/07/202308:00PRNUSKintara Therapeutics Announces Review of Strategic..
12/05/202308:10EDGAR2Form 8-K - Current report
12/05/202308:00PRNUSKintara Therapeutics Granted Extension by Nasdaq to Regain..
11/21/202306:55EDGAR2Form 8-K - Current report
11/13/202315:15EDGAR2Form 8-K - Current report
11/13/202315:10PRNUSKintara Therapeutics Announces Fiscal 2024 First Quarter..
11/13/202315:05EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/31/202307:10EDGAR2Form 8-K - Current report
10/31/202307:00PRNUSKintara Therapeutics Announces Preliminary Topline Results..
10/27/202315:05EDGAR2Form S-1/A - General form for registration of securities..
10/24/202315:43EDGAR2Form S-1/A - General form for registration of securities..
10/10/202315:06EDGAR2Form 8-K - Current report
10/04/202315:35EDGAR2Form S-1 - General form for registration of securities under..
9/26/202315:09EDGAR2Form 8-K - Current report
9/21/202308:35GLOBEDawson James Securities Announces October Date for 8th..
9/19/202315:20EDGAR2Form 8-K - Current report
9/19/202315:16EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
9/18/202315:31EDGAR2Form 8-K - Current report
9/18/202315:25EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
9/11/202315:06EDGAR2Form DEF 14A - Other definitive proxy statements
9/01/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/01/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/01/202317:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
9/01/202315:05EDGAR2Form PRE 14A - Other preliminary proxy statements
6/30/202316:11EDGAR2Form 8-K - Current report